Metro-MN Community Oncology Research Consortium — Minneapolis, Minnesota

Metro-MN Community Oncology Research Consortium is a clinical research site located in Minneapolis, Minnesota, United States 55416.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Metro-MN Community Oncology Research Consortium has participated in 1 clinical trials.

Therapeutic areas: Glioblastoma.

Sponsors: Vascular Biogenics Ltd. operating as VBL Therapeutics.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Metro-MN Community Oncology Research Consortium?

Metro-MN Community Oncology Research Consortium has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Metro-MN Community Oncology Research Consortium conducted?

Metro-MN Community Oncology Research Consortium has 1 clinical trials on record. Their work covers Glioblastoma.

Is Metro-MN Community Oncology Research Consortium accredited by Crixeo Health?

Metro-MN Community Oncology Research Consortium has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Metro-MN Community Oncology Research Consortium?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.